Medtronic PLC- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Medtronic PLC 公司

Medtronic Public Limited Company 是一家總部位於愛爾蘭的公司，提供醫療技術解決方案。該公司的產品類別包括先進外科技術；心律；心血管；消化和胃腸道；耳鼻喉；普通外科；婦科；神經科；口腔頜面；患者監測；腎臟護理；呼吸；脊柱和骨科；手術導航和成像；泌尿科；產品手冊；產品訂購和查詢；以及產品性能和諮詢。其產品包括心臟植入式電子設備 (CIED) 穩定器、主動脈支架移植產品、CareLink 個人治療管理軟件、CareLink Pro 治療管理軟件。其服務和解決方案包括門診手術中心資源、護理管理服務、數字連接信息技術 (IT) 支持、設備服務和支持、創新實驗室、美敦力醫療諮詢和門診鼻竇手術。

公司簡介

公司代碼MDT

公司名稱Medtronic PLC

上市日期Nov 21, 1977

成立日期2014

CEOMr. Geoffrey S. (Geoff) Martha

員工數量- -

證券類型Ordinary Share

年結日Nov 21

公司地址Building Two Parkmore Business Park West

城市DUBLIN

上市交易所NYSE Consolidated

國家Ireland

郵編H91 4K49

電話1135314381700

網址https://www.medtronic.com/

公司代碼MDT

上市日期Nov 21, 1977

成立日期2014

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.03M

+0.45%

Mr. Sean M. Salmon

Executive Vice President, President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Kendall J. (Ken) Powell

Independent Director

47.95K

+4.05%

Mr. Craig Arnold

Lead Independent Director

40.16K

+4.88%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit

39.00K

-1.45%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

30.75K

--

Mr. Scott C. Donnelly

Independent Director

21.52K

+9.50%

名稱

名稱/職務

職務

持股

持股變動

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.03M

+0.45%

Mr. Sean M. Salmon

Executive Vice President, President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Kendall J. (Ken) Powell

Independent Director

47.95K

+4.05%

收入明細

單位: USD更新時間: 4月6日週日

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Surgical & Endoscopy

1.60B

19.25%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.83%

Other

2.29B

27.68%

地區USD

名稱

營收

佔比

United States

4.24B

51.10%

Rest of World

4.03B

48.56%

Ireland

28.00M

0.34%

業務

地區

業務USD

名稱

營收

佔比

Surgical & Endoscopy

1.60B

19.25%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.83%

Other

2.29B

27.68%

股東統計

更新時間: 5月16日週五

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.70%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Global Advisors (US)

4.68%

Capital Research Global Investors

3.24%

JP Morgan Asset Management

2.18%

Other

74.82%

持股股東

佔比

The Vanguard Group, Inc.

9.70%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Global Advisors (US)

4.68%

Capital Research Global Investors

3.24%

JP Morgan Asset Management

2.18%

Other

74.82%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

38.97%

Investment Advisor

36.14%

Research Firm

3.89%

Pension Fund

2.25%

Bank and Trust

2.04%

Hedge Fund

1.91%

Sovereign Wealth Fund

1.25%

Insurance Company

0.38%

Individual Investor

0.25%

Other

12.90%

機構持股

更新時間: 2月20日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

3759

1.13B

87.77%

+9.53M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.32M

2023Q1

3738

1.14B

85.40%

-14.71M

2022Q4

3689

1.13B

84.79%

-25.98M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

123.63M

9.64%

+776.44K

+0.63%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

68.04M

5.31%

+1.54M

+2.32%

Dec 31, 2024

State Street Global Advisors (US)

60.44M

4.71%

-293.90K

-0.48%

Dec 31, 2024

Capital Research Global Investors

33.20M

2.59%

+571.70K

+1.75%

Dec 31, 2024

JP Morgan Asset Management

24.34M

1.9%

+2.87M

+13.36%

Dec 31, 2024

Geode Capital Management, L.L.C.

27.06M

2.11%

+574.05K

+2.17%

Dec 31, 2024

MFS Investment Management

19.23M

1.5%

-3.64M

-15.91%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

14.57M

1.14%

-1.01M

-6.49%

Dec 31, 2024

DWS Investment GmbH

14.66M

1.14%

+197.49K

+1.37%

Dec 31, 2024

BlackRock Financial Management, Inc.

13.22M

1.03%

+764.34K

+6.14%

Dec 31, 2024

持股ETF

更新時間: 6月6日週五

機構名稱

佔比

Absolute Select Value ETF

5.64%

Polen Capital International Growth ETF

4.62%

Cullen Enhanced Equity Income ETF

4.3%

Madison Covered Call ETF

4.15%

iShares U.S. Medical Devices ETF

4.06%

JPMorgan Healthcare Leaders ETF

3.78%

USCF Dividend Income Fund

3.72%

Madison Dividend Value ETF

3.66%

iShares Large Cap Value Active ETF

3.34%

First Trust Active Global Quality Income ETF

3.26%

Absolute Select Value ETF

佔比5.64%

Polen Capital International Growth ETF

佔比4.62%

Cullen Enhanced Equity Income ETF

佔比4.3%

Madison Covered Call ETF

佔比4.15%

iShares U.S. Medical Devices ETF

佔比4.06%

JPMorgan Healthcare Leaders ETF

佔比3.78%

USCF Dividend Income Fund

佔比3.72%

Madison Dividend Value ETF

佔比3.66%

iShares Large Cap Value Active ETF

佔比3.34%

First Trust Active Global Quality Income ETF

佔比3.26%

分紅派息

近5年累計派現 16.68B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Medtronic PLC

87.270USD

Medtronic PLC

87.270

概覽

公司